O'Brien B - Search Results

1

Distinct trajectories of antidepressant response to intravenous ketamine.

O'Brien B, Lijffijt M, Lee J, Kim YS, Wells A, Murphy N, Ramakrishnan N, Swann AC, Mathew SJ. O'Brien B, et al. J Affect Disord. 2021 May 1;286:320-329. doi: 10.1016/j.jad.2021.03.006. Epub 2021 Mar 9. J Affect Disord. 2021. PMID: 33770540

2

Interactions of immediate and long-term action regulation in the course and complications of bipolar disorder.

Lijffijt M, O'Brien B, Salas R, Mathew SJ, Swann AC. Lijffijt M, et al. Philos Trans R Soc Lond B Biol Sci. 2019 Feb 18;374(1766):20180132. doi: 10.1098/rstb.2018.0132. Philos Trans R Soc Lond B Biol Sci. 2019. PMID: 30966917 Free PMC article.

3

Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depression.

O'Brien B, Green CE, Al-Jurdi R, Chang L, Lijffijt M, Iqbal S, Iqbal T, Swann AC, Mathew SJ. O'Brien B, et al. Contemp Clin Trials Commun. 2019 Aug 21;16:100432. doi: 10.1016/j.conctc.2019.100432. eCollection 2019 Dec. Contemp Clin Trials Commun. 2019. PMID: 31508531 Free PMC article.

4

The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression.

O'Brien B, Lijffijt M, Wells A, Swann AC, Mathew SJ. O'Brien B, et al. Pharmaceuticals (Basel). 2019 Sep 11;12(3):133. doi: 10.3390/ph12030133. Pharmaceuticals (Basel). 2019. PMID: 31514448 Free PMC article.

5

A Proof-of-Mechanism Study to Test Effects of the NMDA Receptor Antagonist Lanicemine on Behavioral Sensitization in Individuals With Symptoms of PTSD.

Lijffijt M, Green CE, Balderston N, Iqbal T, Atkinson M, Vo-Le B, Vo-Le B, O'Brien B, Grillon C, Swann AC, Mathew SJ. Lijffijt M, et al. Front Psychiatry. 2019 Dec 13;10:846. doi: 10.3389/fpsyt.2019.00846. eCollection 2019. Front Psychiatry. 2019. PMID: 31920733 Free PMC article.

6

Psychotherapy for Mixed Depression and Mixed Mania.

O'Brien B, Lee D, Swann AC, Mathew SJ, Lijffijt M. O'Brien B, et al. Psychiatr Clin North Am. 2020 Mar;43(1):199-211. doi: 10.1016/j.psc.2019.10.014. Epub 2019 Dec 18. Psychiatr Clin North Am. 2020. PMID: 32008685 Review.

7

Impulsivity and Suicidal Behavior.

Swann AC, Lijffijt M, O'Brien B, Mathew SJ. Swann AC, et al. Curr Top Behav Neurosci. 2020;47:179-195. doi: 10.1007/7854_2020_144. Curr Top Behav Neurosci. 2020. PMID: 32472429

8

Does mismatch negativity have utility for NMDA receptor drug development in depression?

Murphy N, Lijffijt M, Ramakrishnan N, Vo-Le B, Vo-Le B, Iqbal S, Iqbal T, O'Brien B, Smith MA, Swann AC, Mathew SJ. Murphy N, et al. Braz J Psychiatry. 2022 Jan-Feb;44(1):61-73. doi: 10.1590/1516-4446-2020-1685. Braz J Psychiatry. 2022. PMID: 33825765 Free PMC article. Review.

9

Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV-5500) in PTSD: A randomized, double-blind, placebo-controlled trial.

Ramakrishnan N, Lijffijt M, Green CE, Balderston NL, Murphy N, Grillon C, Iqbal T, Vo-Le B, O'Brien B, Murrough JW, Swann AC, Mathew SJ. Ramakrishnan N, et al. Depress Anxiety. 2021 Nov;38(11):1108-1119. doi: 10.1002/da.23194. Epub 2021 Jul 12. Depress Anxiety. 2021. PMID: 34254405 Free PMC article. Clinical Trial.

10

An Update on Community Ketamine Practices.

O'Brien B, Wilkinson ST, Mathew SJ. O'Brien B, et al. Am J Psychiatry. 2022 May;179(5):393-394. doi: 10.1176/appi.ajp.21111086. Am J Psychiatry. 2022. PMID: 35491568 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,618 results

Search Page